3 products were found matching "Cay15639-1"!
No results were found for the filter!
SCH 23390 (hydrochloride)
Item number: Cay15631-10
SCH 23390 is a halobenzazepine that acts as a selective antagonist of the dopamine D1-like receptor subtypes D1 and D5 (Kis = 0.2 and 0.3 nM, respectively). In vivo studies have demonstrated that SCH 23390 can abolish pharmacologically-induced seizures. This compound is useful for studying the role of the dopamine...
| Keywords: | 8-chloro-2,3,4,5-tetrahydro-3-methyl-5R-phenyl-1H-3-benzazepin-7-ol, monohydrochloride |
| Application: | Dopamine receptor D1 / D5 antagonist |
| CAS | 125941-87-9 |
| MW: | 324.2 D |
From 189.00€
*
AB-CHMINACA metabolite M3A
Item number: Cay16391-1
AB-CHMINACA (Cay-15434) is a synthetic cannabinoid (CB) that is an analog of AB-FUBINACA (Cay-14039), a potent agonist of the central CB1 receptor (Ki = 0.9 nM). AB-CHMINACA metabolite M3A is an expected dihydroxylated metabolite produced during metabolism of AB-CHMINACA in the liver. The physiological and...
| Keywords: | N-[[1-[(4-hydroxycyclohexyl)methyl]-1H-indazol-3-yl]carbonyl]-L-valine |
| Application: | Analytical reference standard, expected dihydroxylated synthetic cannabinoid AB-CHMINACA metabolite |
| CAS | 2131173-58-3 |
| MW: | 373.5 D |
From 142.00€
*
Cobimetinib
Item number: Cay19563-5
Cobimetinib is a potent, orally available inhibitor of MEK1 (IC50 = 4.2 nM). It shows more than 100-fold selectivity for MEK when tested against a panel of more than 100 serine-threonine and tyrosine kinases. Cobimetinib induces differentiation and apoptosis in cancer cell lines and is more effective when combined...
| Keywords: | GDC-0973, RG-7420, XL518,... |
| Application: | Antineoplastic, MEK inhibitor |
| CAS | 934660-93-2 |
| MW: | 531.3 D |
From 66.00€
*
